source
- Revolution Medicines' pancreatic cancer therapy Rasonque moves closer to European approval after FDA clearanceRevolution Medicines' experimental drug Rasonque, aimed at treating pancreatic cancer, has received a recommendation for approval from European regulators. The recommendation follows an earlier po…
- China drafts policy to block foreign buyouts of key cell-gene therapy and siRNA platformsChina’s government has released a draft amendment to its export blacklist that would prohibit or tightly control foreign purchases of certain biopharmaceutical platforms. The rule targets propriet…